MHRA Recalled Medicines with Missing Safety Labels

| By | Drug Label, MHRA
0
98

In England, imported medicines have appeared which have apparently been removed or “stolen” from the legal supply chain in order to be reintroduced later into regular sales. With this, both correct transport and appropriate storage conditions are no longer guaranteed.

On the products concerned

  • the thrombosis syringes Clexane
  • the antiepileptic Vimpat
  • the dopamine antagonist Neupro (rotigotine)

a security label is missing, which led to the assumption that they were illegally smuggled into the supply chain. The medicinal products originally imported from Italy are said to be original products and are unlikely to have been adulterated. Patients are asked to return affected medicine packs to pharmacies. The affected products were parallel imported by B&S Healthcare and then relabelled in Great Britain.

SOURCE: gmp-verlag.de
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.